The future of adjuvant therapies is promising, with ongoing research and advancements in the field. Personalized medicine, which tailors treatment based on the genetic makeup of both the patient and the tumor, is becoming increasingly prevalent. Advances in molecular biology and genomics are paving the way for more targeted and effective adjuvant therapies, with fewer side effects. Immunotherapy is also a rapidly evolving field, offering new hope for more durable and long-lasting cancer control.
